Cleared Traditional

K790734 - PREGNOSTICON PREGNANCY TEST KIT

K790734 is the FDA 510(k) clearance for PREGNOSTICON PREGNANCY TEST KIT by Organon, Inc.. It is a Class 2 Chemistry device (product code JHJ) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K790734 · Organon, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1979
Decision
60d
Days
Class 2
Risk

K790734 is an FDA 510(k) clearance for the PREGNOSTICON PREGNANCY TEST KIT. Classified as Agglutination Method, Human Chorionic Gonadotropin (product code JHJ), Class II - Special Controls.

Submitted by Organon, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 15, 1979 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Organon, Inc. devices

Submission Details

510(k) Number K790734 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 1979
Decision Date June 15, 1979
Days to Decision 60 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 88d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JHJ Agglutination Method, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHJ Agglutination Method, Human Chorionic Gonadotropin

All 42
Devices cleared under the same product code (JHJ) and FDA review panel - the closest regulatory comparables to K790734.
UCG-BETA STAT
K802421 · Armkel, LLC · Oct 1980
UCG-BETA SLIDE
K802435 · Armkel, LLC · Oct 1980
SENSI-SLIDE
K792657 · Hoffmann-La Roche, Inc. · Jan 1980
SENSI-TEX
K790267 · Hoffmann-La Roche, Inc. · Mar 1979
PREGNANCY TEST KIT, DAISY 2 IN HOME
K790002 · Boehringer Mannheim Corp. · Feb 1979